(19)
(11)EP 2 845 596 A3

(12)EUROPEAN PATENT APPLICATION

(88)Date of publication A3:
15.07.2015 Bulletin 2015/29

(43)Date of publication A2:
11.03.2015 Bulletin 2015/11

(21)Application number: 14180931.9

(22)Date of filing:  10.01.2001
(51)Int. Cl.: 
A61K 31/70  (2006.01)
A61K 31/727  (2006.01)
C07H 5/04  (2006.01)
C07H 21/00  (2006.01)
C08B 37/08  (2006.01)
A61K 47/48  (2006.01)
A61K 31/715  (2006.01)
A61K 31/695  (2006.01)
C07H 5/06  (2006.01)
C07H 13/04  (2006.01)
C08B 37/10  (2006.01)
(84)Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

(30)Priority: 10.01.2000 US 174907 P
10.01.2000 US 174905 P

(62)Application number of the earlier application in accordance with Art. 76 EPC:
01900237.7 / 1471870

(71)Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
9139002 Jerusalem (IL)

(72)Inventors:
  • Shoseyov, David
    99797 Carmei Yosef (IL)
  • Golomb, Gershon
    Efrat 90435 (IL)
  • Reich, Reuven
    76288 Rehovot (IL)
  • Ginsburg, Isaac
    92509 Jerusalem (IL)
  • Higazi, Abd-al-Roof
    99761 D.N. Shimshon (IL)
  • Ligumski, Moshe
    92630 Jerusalem (IL)
  • Krimsky, Miron
    96925 Jerusalem (IL)
  • Ojcius, David
    94300 Vincennes (FR)
  • Van der Woude, Fokko Johannes
    deceased (DE)
  • Schnitzer, Edit
    69051 Tel Aviv (IL)
  • Yard, Benito Antonio
    67251 Freinsheim (DE)
  • Yedgar, Saul
    95405 Jerusalem (IL)

(74)Representative: Pearl Cohen Zedek Latzer Baratz UK LLP 
The Gridiron Building One Pancras Square
London N1C 4AG
London N1C 4AG (GB)

  


(54)Use of lipid conjugates in the treatment of disease


(57) A phospholipid conjugate according to the general formula (I)

or according to the general formula (II)

for use in the treatment or prevention of a disorder selected from skin hypersensitivity, respiratory disease, eye disorder, and inflammatory bowel disease.